Market By Application, Modality And Country | Forecast 2019-2028
An analysis by Triton Market Research has concluded that the European extra corporeal membrane oxygenation (ECMO) system market is expected to expand at a CAGR of 4.63% during the forthcoming period 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries evaluated in the Europe extra corporeal membrane oxygenation (ECMO) system market are:
• Italy
• The United Kingdom
• Germany
• Russia
• France
• Spain
• Rest of Europe
In Germany, approximately 48,000 heart bypasses were conducted in 2017. Patients are increasingly undergoing cardiopulmonary bypass procedures owing to the rising cardiovascular diseases. About 29% of surgical operations were performed related to diseases associated with the circulatory system.This is ultimately increasing the use of extra corporeal membrane oxygenation (ECMO) system in the country. Therefore, the rising number of cardiopulmonary bypass procedures and the growing incidence of cardiovascular diseases are driving the ECMO system market.
Cardiovascular disease is among the leading causes of death in France. Due to the high incidence of these chronic diseases, the ECMO market is expected to grow in the upcoming years. There are about five ECMO centers registered with extra corporeal life support in the country. Besides, the use of extracorporeal membrane oxygenation has increased after the H1N1 pandemic that was spread in 2009. There are ECMO mobile units implemented in the country as a support for cardiac or respiratory failure. In addition, the use of VV-ECMO (Veno-Venous extra corporeal membrane oxygenation (ECMO) system has substantially increased over the last decade owing to technological advancements. These factors are likely to aid the studied market over the forecast years.
Established in 2013, Hemovent is a medical technology company involved in the development of a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. It aims to develop an innovative solution, to help patients with lung and heart dysfunction. It is headquartered in Aachen, Germany. The MOBYBOX is a product provided by the company, designed to support heart and lung function. It generally rescues patients with acute cardiac or respiratory failure.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1.MARKET DEFINITION
2.2.PORTER’S FIVE FORCES MODEL
2.2.1.THREAT OF NEW ENTRANTS
2.2.2.THREAT OF SUBSTITUTE PRODUCTS
2.2.3.BARGAINING POWER OF BUYERS
2.2.4.BARGAINING POWER OF SUPPLIERS
2.2.5.COMPETITIVE RIVALRY
2.3.IMPACT OF COVID-19 ON ECMO SYSTEM MARKET
2.4.MARKET ATTRACTIVENESS INDEX
2.5.VENDOR SCORECARD
2.6.KEY INSIGHTS
2.7.MARKET DRIVERS
2.7.1.RISING POPULARITY OF ECMO TECHNOLOGY
2.7.2.INCREASING PREVALENCE OF CHRONIC DISORDERS
2.8.MARKET RESTRAINTS
2.8.1.SIGNIFICANT COST OF ECMO SYSTEMS
2.8.2.EXISTENCE OF ALTERNATIVE TECHNIQUES
2.9.MARKET OPPORTUNITIES
2.9.1.GROWING AWARENESS REGARDING APPLICATIONS OF ECMO SYSTEMS
2.9.2.ADVANCEMENT IN TECHNOLOGY
2.10.MARKET CHALLENGES
2.10.1.LACK OF SPECIALIZED SKILLS FOR OPERATION
2.10.2.RISKS ASSOCIATED WITH ECMO PROCEDURES
3. EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET OUTLOOK - BY APPLICATION
3.1.RESPIRATORY
3.2.CARDIAC
3.3.EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
4. EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET OUTLOOK - BY MODALITY
4.1.VENO-VENOUS
4.2.VENO-ARTERIAL
4.3.OTHER MODALITIES
5. EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET – EUROPE
5.1.UNITED KINGDOM
5.2.GERMANY
5.3.FRANCE
5.4.ITALY
5.5.RUSSIA
5.6.SPAIN
5.7.REST OF EUROPE
6. COMPANY PROFILES
6.1.HEMOVENT GMBH
6.2.LIVANOVA PLC
6.3.MICROPORT SCIENTIFIC CORPORATION
6.4.TERUMO MEDICAL CORPORATION
6.5.ELSIUS BIOMEDICAL INC
6.6.ABBOTT LABORATORIES
6.7.ALUNG TECHNOLOGIES INC
6.8.EUROSETS
6.9.SPECTRUM MEDICAL
6.10.XENIOS AG (FRESENIUS SE & CO KGAA)
6.11.MEDTRONIC PLC
6.12.GETINGE AB
6.13.NIPRO CORPORATION
6.14.ORIGEN BIOMEDICAL INC
7. RESEARCH METHODOLOGY & SCOPE
7.1.RESEARCH SCOPE & DELIVERABLES
7.1.1.OBJECTIVES OF STUDY
7.1.2.SCOPE OF STUDY
7.2.SOURCES OF DATA
7.2.1.PRIMARY DATA SOURCES
7.2.2.SECONDARY DATA SOURCES
7.3.RESEARCH METHODOLOGY
7.3.1.EVALUATION OF PROPOSED MARKET
7.3.2.IDENTIFICATION OF DATA SOURCES
7.3.3.ASSESSMENT OF MARKET DETERMINANTS
7.3.4.DATA COLLECTION
7.3.5.DATA VALIDATION & ANALYSIS
TABLE 1 EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, 2019-2028 ($ MILLION)
TABLE 4 EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, 2019-2028 ($ MILLION)
TABLE 5 EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, 2019-2028 ($ MILLION)
FIGURE 1 EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 2 LIST OF CHRONIC DISEASES
FIGURE 3 EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 ($ MILLION)
FIGURE 4 EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 ($ MILLION)
FIGURE 5 EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 ($ MILLION)
FIGURE 6 EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 ($ MILLION)
FIGURE 7 EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 ($ MILLION)
FIGURE 8 EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 ($ MILLION)
FIGURE 9 UNITED KINGDOM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 10 GERMANY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 11 FRANCE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 12 ITALY EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 13 RUSSIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 14 SPAIN EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)
FIGURE 15 REST OF EUROPE EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET 2019-2028 ($ MILLION)